Latest News & Features
Europe
Dennis Waller discusses how differing interpretations of the Bolar exemption may affect clinical trials in the UK. 3 November 2014
Europe
Richard Bassett and Richard Wells look at what EU-based companies must consider in order to comply with the Nagoya Protocol, the regulation aimed at curbing biopiracy. 3 November 2014
Americas
Who has legal interest in the grant of sanitary registrations for follow-on biologics? José Trigueros examines a recent case in Mexico that could have far-reaching ramifications. 3 November 2014
Americas
Canada’s highest court is set to hear a hotly anticipated dispute pitting generic company Apotex against drug companies Sanofi and Bristol-Myers Squibb (BMS). 3 November 2014
Americas
Biotechnology company Amgen has filed a lawsuit against Sanofi and Regeneron Pharmaceuticals accusing the pair of infringing three patents. 3 November 2014
Asia
Indian pharmaceutical company Intas Pharmaceuticals has been granted an injunction preventing a rival from marketing an anti-epilepsy drug it said infringed one of its trademarks. 30 October 2014
Asia
A recent decision from the IPAB on the patent eligibility of biological processes could change the biotech playing field in India, say Swarup Kumar and Shivaarti Bajaj. 29 October 2014
Biotechnology
Should it be possible for a drug maker to stop the owner of a patented ingredient from obtaining an SPC? Ashley Roughton examines the CJEU’s opinion on Eli Lilly v HGS. 29 October 2014
Americas
In the competitive world of cancer treatment it’s becoming ever more important to stand out from the crowd. LSIPR speaks to TapImmune’s chief executive Glynn Wilson on why he thinks the company does. 29 October 2014